Clinical Trial Update: A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body [Phase 1]

View source ↗

Summary

Phase 1 study in healthy men to assess pharmacokinetics and processing of BI 1265162; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• BI 1265162 (BI 1265162)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy Volunteers | Phase 1 | Status: TERMINATED | Results posted: 2022-02-23